Bausch Health Companies (BHC) EPS (Basic) Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bausch Health Companies (BHC) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 15.17% |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | -35.06% |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | -34.99% |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 41.17% |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 110.80% |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 52.36% |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 8.40% |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 31.64% |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.80% |
| Mar 31, 2026 | -88.26% |
| Dec 31, 2025 | 37.41% |
| Sep 30, 2025 | -24.03% |
| Jun 30, 2025 | 42.59% |
| Mar 31, 2025 | -8.35% |
| Dec 31, 2024 | 9.90% |
| Sep 30, 2024 | -35.18% |
| Jun 30, 2024 | 88.19% |
| Mar 31, 2024 | 50.21% |
| Dec 31, 2023 | 33.14% |
| Sep 30, 2023 | -93.42% |
| Jun 30, 2023 | 27.66% |
| Mar 31, 2023 | -10.18% |
| Dec 31, 2022 | 35.93% |
| Sep 30, 2022 | 115.41% |
| Jun 30, 2022 | 7.55% |
| Mar 31, 2022 | -7.31% |
| Dec 31, 2021 | 30.16% |
| Sep 30, 2021 | 36.32% |